Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003016.pdf 0001562180-18-003016.rtf 0001562180-18-003016.xls View HTML
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003015.pdf 0001562180-18-003015.rtf 0001562180-18-003015.xls View HTML
June 15, 2018	8-K	Report of unscheduled material events or corporate event	0001193125-18-193742.pdf 0001193125-18-193742.rtf 0001193125-18-193742.xls View HTML
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003020.pdf 0001562180-18-003020.rtf 0001562180-18-003020.xls View HTML
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003014.pdf 0001562180-18-003014.rtf 0001562180-18-003014.xls View HTML
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003019.pdf 0001562180-18-003019.rtf 0001562180-18-003019.xls View HTML
June 15, 2018	4	Statement of changes in beneficial ownership of securities	0001562180-18-003018.pdf 0001562180-18-003018.rtf 0001562180-18-003018.xls View HTML
May 9, 2018	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-18-012395.pdf 0001564590-18-012395.rtf 0001564590-18-012395.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
April 30, 2018	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-18-143058.pdf 0001193125-18-143058.rtf 0001193125-18-143058.xls View HTML
April 30, 2018	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-18-143093.pdf 0001193125-18-143093.rtf 0001193125-18-143093.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax